From a drop to the ocean: an immersion in individualized medicine

There are currently approximately one hundred biomarkers used in clinical practice, very few (a drop in the ocean) in comparison with the large numbers acclaimed in more than 150,000 scientific papers; intriguingly, most of these promising biomarkers will never become part of routine clinical practice. The ability of high throughput proteomics, metabolomics and other 'omics' platforms to profile a large number of analytes in a single array is increasing the complexity of biomarker validation. This innovation calls for global re-thinking of the role of clinical pathologists in transforming experimental data into clinically available tests. It has become more and more clear that health and disease can only be studied in an outstanding way by using complex systems such as integrative systems biology, systems medicine, and network medicine. In particular metabolomics will contribute to guiding the medicine of the past, towards the medicine of the present and the medicine of the future and perhaps will actually contribute to unveil many mysteries of medicine. The dynamic range of the metabolome is revealed by subjecting the organism to physiological and pathological changes in the state of health: this means that we are quite different from each other and these differences are accentuated when faced with changes, especially if very significant and/or extreme, for example, in cases of fasting or asphyxia. Indeed, in the next few years we will witness a profound change in medicine and healthcare as a result of progresses in technology and the ability to analyze large amounts of data from single patients (Big Data). Only by being aware of complexity and biological variability, by improving our knowledge, by feeding and treating different individuals in different ways, and most of all by better defining the state of health of each individual and his/her resilience, will medicine be in a position to respond in a personalized and customized way (and not approximately and epidemiologically) to the problems of human health. Proceedings of the 9 th International Workshop on Neonatology · Cagliari (Italy) · October 23 rd -26 th , 2013 · Learned lessons, changing practice and cutting-edge research

[1]  Rawi Ramautar,et al.  Human metabolomics: strategies to understand biology. , 2013, Current opinion in chemical biology.

[2]  L. Atzori,et al.  Metabolomics in the developing infant , 2013, Current opinion in pediatrics.

[3]  G. Buonocore,et al.  Proteomics and metabolomics: can they solve some mysteries of the newborn? , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[4]  R. Gerszten,et al.  Toward new biomarkers of cardiometabolic diseases. , 2013, Cell metabolism.

[5]  L. Atzori,et al.  Metabolomics in neonatal life. , 2013, Early human development.

[6]  L. Atzori,et al.  Metabolomics in neonatology: fact or fiction? , 2013, Seminars in fetal & neonatal medicine.

[7]  V. Fanos Pediatric and neonatal individualized Medicine: care and cure for each and everyone , 2012 .

[8]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[9]  Fabian J Theis,et al.  The dynamic range of the human metabolome revealed by challenges , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  G. Poste Bring on the biomarkers , 2011, Nature.

[11]  L. Barberini,et al.  A metabolomic approach in an experimental model of hypoxia-reoxygenation in newborn piglets: urine predicts outcome , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[12]  V. Fanos,et al.  Personalized Neonatal Medicine , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[13]  J Bruce German,et al.  Looking into the future of foods and health. , 2008, Innovation.

[14]  J. German,et al.  Personalizing foods: is genotype necessary? , 2008, Current opinion in biotechnology.

[15]  M. Tewari,et al.  The Limits of Reductionism in Medicine: Could Systems Biology Offer an Alternative? , 2006, PLoS medicine.

[16]  L. Barberini,et al.  Urinary metabolomics in newborns and infants. , 2012, Advances in clinical chemistry.

[17]  Reza Resoulpour Predicting Later-Life Outcomes of Early-Life Exposures , 2011 .

[18]  N. Gulbahce,et al.  Network medicine: a network-based approach to human disease , 2010, Nature Reviews Genetics.

[19]  D. Accili,et al.  Annals of the New York Academy of Sciences Application of Combined Omics Platforms to Accelerate Biomedical Discovery in Diabesity , 2022 .